|
Description:
|
|
Jon Boyar from the Boyar Value Group returns to the podcast to discuss his high conviction thesis for Scotts Miracle-Gro (SMG). SMG was a massive COVID beneficiary, and shares have sold off in kind with other COVID beneficiaries. Jon thinks the market is too pessimistic here, SMG's brands have Coke like market share, and the company has a rapidly growing "picks and shovels" cannabis business that he believes investors are basically getting for free at current prices
You can find all my writings here: https://yetanothervalueblog.substack.com/ My notes on SMG: https://twitter.com/AndrewRangeley/status/1489600380854013952?s=20&t=c24bhjV0UhOWlZWjgULoCw Boyar's interview w/ SMG's CEO: https://www.boyarvaluegroup.com/podcasts/james-hagedorn-scotts-miracle-gro-chief-executive-officer-and-chairman-of-the-board-on-the-tremendous-opportunity-in-the-cannabis-space-potentially-spinning-off-the-fast-growing-hawthorne-division/ Boyar's SMG overview: https://www.lp.boyarvaluegroup.com/smg2021 Boyar's Forgotten Forty: https://www.lp.boyarvaluegroup.com/andrewwalker
Chapters 0:00 Intro 1:35 SMG Overview 5:50 Why are SMG's brands so dominant? 9:50 Customer concentration risk for SMG 11:55 What happens to earnings as they lapse the "COVID boom"? 17:50 Discussing Hawthorne 21:30 What is Hawthorne's moat? 24:45 Federal legalization and Hawthorne's sales distribution 27:40 Why is Hawthorne's growth slowing right now? 29:45 Hawthorne's cannabis investment strategy 34:00 How SMG got into Hawthorne and look at it long term 36:20 Breaking down SMG's SOTP 40:00 The rationale for a potential Hawthorne spin 45:40 Closing SMG thoughts 48:25 Other interesting forgotten 40 names |